He Jiankui stands by a controversial research approach that landed him in prison as he aims to tackle Alzheimer’s disease.

Base editing corrected a mutation that causes macular degeneration, highlighting the potential of gene therapy to treat ...

Science is discovery and discovery evolve. Few discoveries have elicited as much excitement in the scientific world in recent times ...

Crispr Therapeutics said Chief Operating Officer Julianne Bruno would depart the company to pursue other opportunities, effective April 11. Bruno joined the gene-editing company in 2019 and stepped ...

We recently published a list of 10 Hot Biotech Stocks Under $5. In this article, we are going to take a look at where Kodiak ...

We recently published a list of 10 Hot Biotech Stocks Under $5. In this article, we are going to take a look at where Cardiff ...

We recently published a list of 10 Hot Biotech Stocks Under $5. In this article, we are going to take a look at where ...

A Peninsula biotech company raised $68 million from investors — including a venture philanthropy fund started by Lululemon ...

The startup is using CRISPR tools to stop errant expression of a gene linked to facioscapulohumeral muscular dystrophy, a ...

In this week’s edition of the biotech bi-weekly, learn more about Thermo Fisher’s new system for automating complex sample ...

Racehorses in Britain are to be tested for gene doping as part of a new initiative by the British Horseracing Authority.

Verve received FDA IND clearance for VERVE-102 to treat HeFH, adding new trial sites in the United States. Read more about ...